vs
Side-by-side financial comparison of G III APPAREL GROUP LTD (GIII) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $988.6M, roughly 1.1× G III APPAREL GROUP LTD). G III APPAREL GROUP LTD runs the higher net margin — 8.2% vs -127.8%, a 136.0% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -9.0%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $-106.4M). Over the past eight quarters, G III APPAREL GROUP LTD's revenue compounded faster (13.7% CAGR vs 1.3%).
G III Apparel Group is a global fashion company that designs, sources, manufactures, markets and distributes apparel, footwear, and accessories under a range of owned and licensed well-known brands. It serves department stores, specialty retailers, and e-commerce platforms across North America, Europe, and other key global markets, catering to casual, sportswear, and premium fashion consumer segments.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
GIII vs PRGO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $988.6M | $1.1B |
| Net Profit | $80.6M | $-1.4B |
| Gross Margin | 38.6% | 32.6% |
| Operating Margin | 11.4% | -116.0% |
| Net Margin | 8.2% | -127.8% |
| Revenue YoY | -9.0% | -2.5% |
| Net Profit YoY | -29.8% | -3093.9% |
| EPS (diluted) | $1.84 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $988.6M | $1.1B | ||
| Q3 25 | $613.3M | $1.0B | ||
| Q2 25 | $583.6M | $1.1B | ||
| Q1 25 | $839.5M | $1.0B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $644.8M | $1.1B | ||
| Q2 24 | $609.7M | $1.1B | ||
| Q1 24 | $764.8M | $1.1B |
| Q4 25 | $80.6M | $-1.4B | ||
| Q3 25 | $10.9M | $7.5M | ||
| Q2 25 | $7.8M | $-8.4M | ||
| Q1 25 | $48.8M | $-6.4M | ||
| Q4 24 | $114.8M | $-44.4M | ||
| Q3 24 | $24.2M | $-21.0M | ||
| Q2 24 | $5.8M | $-108.4M | ||
| Q1 24 | $28.9M | $2.0M |
| Q4 25 | 38.6% | 32.6% | ||
| Q3 25 | 40.8% | 36.1% | ||
| Q2 25 | 42.2% | 34.4% | ||
| Q1 25 | 39.5% | 37.6% | ||
| Q4 24 | 39.8% | 33.9% | ||
| Q3 24 | 42.8% | 37.2% | ||
| Q2 24 | 42.5% | 37.0% | ||
| Q1 24 | 36.9% | 33.1% |
| Q4 25 | 11.4% | -116.0% | ||
| Q3 25 | 2.7% | 7.0% | ||
| Q2 25 | 1.5% | 4.3% | ||
| Q1 25 | 8.5% | 4.5% | ||
| Q4 24 | 15.3% | 10.0% | ||
| Q3 24 | 6.4% | 7.4% | ||
| Q2 24 | 2.2% | -2.5% | ||
| Q1 24 | 6.1% | -5.1% |
| Q4 25 | 8.2% | -127.8% | ||
| Q3 25 | 1.8% | 0.7% | ||
| Q2 25 | 1.3% | -0.8% | ||
| Q1 25 | 5.8% | -0.6% | ||
| Q4 24 | 10.6% | -3.9% | ||
| Q3 24 | 3.8% | -1.9% | ||
| Q2 24 | 1.0% | -10.2% | ||
| Q1 24 | 3.8% | 0.2% |
| Q4 25 | $1.84 | $-10.23 | ||
| Q3 25 | $0.25 | $0.05 | ||
| Q2 25 | $0.17 | $-0.06 | ||
| Q1 25 | $1.00 | $-0.05 | ||
| Q4 24 | $2.55 | $-0.32 | ||
| Q3 24 | $0.53 | $-0.15 | ||
| Q2 24 | $0.12 | $-0.79 | ||
| Q1 24 | $0.59 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.1M | — |
| Total DebtLower is stronger | $6.5M | — |
| Stockholders' EquityBook value | $1.8B | $2.9B |
| Total Assets | $2.8B | $8.5B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $184.1M | — | ||
| Q3 25 | $301.8M | $432.1M | ||
| Q2 25 | $257.8M | $454.2M | ||
| Q1 25 | $181.4M | $409.9M | ||
| Q4 24 | $104.7M | $558.8M | ||
| Q3 24 | $414.8M | $1.5B | ||
| Q2 24 | $508.4M | $542.8M | ||
| Q1 24 | $507.8M | $658.5M |
| Q4 25 | $6.5M | — | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $3.0M | — | ||
| Q4 24 | $213.9M | — | ||
| Q3 24 | $402.5M | — | ||
| Q2 24 | $402.7M | — | ||
| Q1 24 | $402.8M | — |
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.7B | $4.4B | ||
| Q2 25 | $1.7B | $4.5B | ||
| Q1 25 | $1.7B | $4.4B | ||
| Q4 24 | $1.6B | $4.3B | ||
| Q3 24 | $1.5B | $4.6B | ||
| Q2 24 | $1.5B | $4.5B | ||
| Q1 24 | $1.6B | $4.7B |
| Q4 25 | $2.8B | $8.5B | ||
| Q3 25 | $2.7B | $10.1B | ||
| Q2 25 | $2.4B | $10.1B | ||
| Q1 25 | $2.5B | $9.8B | ||
| Q4 24 | $2.8B | $9.6B | ||
| Q3 24 | $2.7B | $11.2B | ||
| Q2 24 | $2.6B | $10.4B | ||
| Q1 24 | $2.7B | $10.6B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.27× | — | ||
| Q2 24 | 0.26× | — | ||
| Q1 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-97.3M | $175.4M |
| Free Cash FlowOCF − Capex | $-106.4M | $148.6M |
| FCF MarginFCF / Revenue | -10.8% | 13.4% |
| Capex IntensityCapex / Revenue | 0.9% | 2.4% |
| Cash ConversionOCF / Net Profit | -1.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $367.7M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-97.3M | $175.4M | ||
| Q3 25 | $75.1M | $51.7M | ||
| Q2 25 | $93.8M | $75.9M | ||
| Q1 25 | $333.4M | $-64.5M | ||
| Q4 24 | $-111.8M | $312.6M | ||
| Q3 24 | $49.3M | $42.2M | ||
| Q2 24 | $45.5M | $9.5M | ||
| Q1 24 | $361.3M | $-1.4M |
| Q4 25 | $-106.4M | $148.6M | ||
| Q3 25 | $64.7M | $29.8M | ||
| Q2 25 | $85.7M | $56.7M | ||
| Q1 25 | $323.7M | $-90.0M | ||
| Q4 24 | $-120.3M | $274.9M | ||
| Q3 24 | $38.8M | $15.1M | ||
| Q2 24 | $32.8M | $-18.9M | ||
| Q1 24 | $352.3M | $-26.5M |
| Q4 25 | -10.8% | 13.4% | ||
| Q3 25 | 10.6% | 2.9% | ||
| Q2 25 | 14.7% | 5.4% | ||
| Q1 25 | 38.6% | -8.6% | ||
| Q4 24 | -11.1% | 24.2% | ||
| Q3 24 | 6.0% | 1.4% | ||
| Q2 24 | 5.4% | -1.8% | ||
| Q1 24 | 46.1% | -2.4% |
| Q4 25 | 0.9% | 2.4% | ||
| Q3 25 | 1.7% | 2.1% | ||
| Q2 25 | 1.4% | 1.8% | ||
| Q1 25 | 1.2% | 2.4% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 1.6% | 2.5% | ||
| Q2 24 | 2.1% | 2.7% | ||
| Q1 24 | 1.2% | 2.3% |
| Q4 25 | -1.21× | — | ||
| Q3 25 | 6.86× | 6.89× | ||
| Q2 25 | 12.09× | — | ||
| Q1 25 | 6.83× | — | ||
| Q4 24 | -0.97× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 7.84× | — | ||
| Q1 24 | 12.52× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
